 Wells Fargo Company MN lifted its position in BioDelivery Sciences International, Inc. NASDAQ:BDSI by 73.3 during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 300,305 shares of the specialty pharmaceutical companys stock after buying an additional 127,021 shares during the quarter. Wells Fargo ... 